Shuttle Pharmaceuticals Holdings, Inc.
Price Action
Technical Summary
CONSOLIDATINGShuttle Pharmaceuticals Holdings, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 88), indicating clear outperformance against the broad market. Earnings growth of 43% provides fundamental context to the price action. However, with RSI at 84, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.42 | +65.85% | ABOVE |
| 50 SMA | $1.43 | +180.32% | ABOVE |
| 100 SMA | $1.19 | +237.56% | ABOVE |
| 150 SMA | $1.41 | +184.96% | ABOVE |
| 200 SMA | $1.72 | +133.40% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SHPH in an uptrend right now?
SHPH has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is SHPH overbought or oversold?
SHPH's RSI (14) is 84. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is SHPH outperforming the market?
SHPH has a Relative Strength (RS) Rating of 88 out of 99. Yes, SHPH is a market leader, outperforming 88% of all stocks over the past 12 months.
Where is SHPH in its 52-week range?
SHPH is trading at $4.02, which is 7% of its 52-week high ($55.90) and 7% above its 52-week low ($0.40).
How volatile is SHPH?
SHPH has a Beta of 1.98 and 52-week volatility of 499%. It's more volatile than the S&P 500 - expect bigger swings.